Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices 41511 

1 (FDA has verified the Web site address, but FDA 

is not responsible for any subsequent changes to the 

Web site after this document publishes in the 

Federal Register.) 

among the States and the Federal 

Government concerning radiation 

control. This forum has made it possible 

for State and Federal agencies to work 

together to study existing and potential 

radiological health problems of mutual 

interest and to apply their increasingly 

limited resources with maximum 

efficiency in seeking ways to address 

these problems, fostering coordination, 

and providing original views. 

II. Award Information 

The objective of this cooperative 

agreement is to coordinate Federal, 

State, and Tribal activities to achieve 

effective solutions to present and future 

radiation control problems. The 

recipient of this cooperative agreement 

award will be expected to obtain the 

States’ cooperation and participation on 

committees and working groups 

established to deal with individual 

problems. The recipient will also plan 

and facilitate an annual meeting, and 

develop and offer educational activities 

to demonstrate mutually beneficial 

techniques, procedures, and systems 

relevant to the mission of assuring 

radiation protection. The recipient will 

establish committees to address, 

evaluate, and offer solutions for a wide 

range of radiation health and protection 

issues. Examples of relevant areas of 

interest include, but are not limited to: 

(1) The application of x-rays to the 

healing arts, (2) the application of 

medical/nonmedical ionizing radiation, 

and (3) the control and mitigation of 

radiation exposure from all sources. 

Copyright Material: Applicants and 

applicants’ subgrantees and 

subcontractors must ensure that any 

projects developed in whole or in part 

with Federal funds will be made 

available to other State, territorial, local, 

and tribal agencies by FDA or its agents. 

Any copyrighted or copyrightable works 

shall be subject to a royalty-free, 

nonexclusive, and irrevocable license to 

the Federal Government to reproduce, 

publish, or otherwise use them, and to 

authorize others to do so for Federal 

Government purposes. 

III. Eligibility Information 

This cooperative agreement is 

available to any domestic private or 

public nonprofit organization (including 

State and local units of government) and 

to any domestic for-profit organization. 

For-profit organizations must exclude 

fees or profit from their requested 

support. Organizations described in 

section 501(c)(4) of the Internal Revenue 

Code of 1968 that engage in lobbying are 

not eligible to receive awards. 

IV. Submission Information/ 

Requirements 

Applications for this program must be 

made electronically. To apply, 

applicants should visit http:// 

www.grants.gov1 and follow the 

instructions under ‘‘Apply for Grants.’’

The required application, SF424 

(Research & Related) (also referred to as 

the ‘‘SF424 (R&R)’’), can be completed 

and submitted online. The package 

should be labeled ‘‘Response to FDA 

RFA number is FD07–004’’. If you 

experience technical difficulties with 

your online submission, you should 

contact the Grants.gov Customer 

Response Center. Information about 

submitting an application electronically 

can be found at http://www.grants.gov. 

In order to apply electronically, the 

applicant must have a DUNS number 

and register in the Central Contractor 

Registration (CCR) database. In addition, 

applicants will be required to register 

with the Credential Provider. 

Information about this is available at 

http://apply.grants.gov/OrcRegister,1 or 

by calling ORC’s help desk at 800–816–

5548. 

Dun and Bradstreet Number (DUNS): 

As of October 1, 2003, applicants are 

required to have a DUNS number to 

apply for a grant or cooperative 

agreement from the Federal 

Government. The DUNS number is a 9- 

digit identification number that 

uniquely identifies business entities. 

Obtaining a DUNS number is easy and 

there is no charge. To obtain a DUNS 

number, call Dun and Bradstreet at 1–

866–705–5711 and identify yourself as a 

Federal grant applicant. 

Central Contractor Registration: 

Applicants must also register in the 

Central Contractor Registration (CCR) 

database. Applicants must have a DUNS 

number to begin registration in the CCR 

database. The CCR is a database is a 

government wide repository of 

commercial and financial information 

for all organizations conducting 

business with the Federal Government. 

Registration with CCR will eventually 

become a requirement for grant 

applicants and is consistent with the 

government wide management reform to 

create a citizen-centered Web presence 

and build e-gov infrastructures in and 

across agencies to establish a ‘‘single 

face to industry.’’ The preferred method 

for completing registration is on the 

Internet at http://www.ccr.gov.1 This 

Web site provides a CCR handbook with 

detailed information on data that 

applicants will need prior to beginning 

the online registration, as well as steps 

to walk applicants through the 

registration process. 

Additional information concerning 

the application process for this 

cooperative agreement can be found on 

FDA’s Web site (http://www.fda.gov/ 

cdrh) and also through the Grants.gov 

Web site (http://www.grants.gov). 

Submission Date: The application 

receipt date August 14, 2007. No 

supplemental or addendum material 

will be accepted after the receipt date. 

V. Agency Contacts 

For additional information regarding 

the administrative and financial 

management aspects of this notice, 

contact Gladys M. Bohler, Food and 

Drug Administration (HFA–500), 5630 

Fishers Lane, Rm. 2105, Rockville, MD 

20857; 301–827–7168, FAX: 301–827–

7101; e-mail: gladys.melendezbohler@fda.hhs.gov. 

For additional information regarding 

the programmatic aspects of this notice, 

contact Sara Sutphin, Center for Devices 

and Radiological Health (HFZ–205), 

Food and Drug Administration, 1350 

Piccard Dr., Rockville, MD 20850; 240–

276–3225, FAX: 240–276–3201; e-mail: 

Sara.Sutphin@fda.hhs.gov. 

Dated: July 23, 2007. 

Jeffrey Shuren, 

Assistant Commissioner for Policy. 

[FR Doc. E7–14610 Filed 7–27–07; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Proposed collection; Comment 

Request; Physicians’ Experience of 

Ethical Dilemmas and Resource 

Allocation 

SUMMARY: In accordance with the 

Paperwork Reduction Act of 1995 (Pub. 

L. 104–13) and Office of Management 

and Budget (OMB) regulations at 5 CFR 

Part 1320 (60 FR 44978, August 29, 

1995), this notice announces the 

intention of the Department of 

Bioethics, National Institutes of Health 

(NIHDCB) to request approval for a new 

information collection, Physicians’

Experience of Ethical Dilemmas and 

Resource Allocation. The proposed 

information collection was previously 

published in the Federal Register on 

May 17, 2007, on pages 27817–18 and 

allowed 60–days for public comment. 

Two public comments were received. 

The purpose of this notice is to allow an 

additional 30 days for public comment. 

mstockstill on PROD1PC66 with NOTICES

41512 Federal Register / Vol. 72, No. 145 / Monday, July 30, 2007 / Notices 

The National Institutes of Health may 

not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Proposed Collection: Title: 

Physicians’ Experience of Ethical 

Dilemmas and Resource Allocation. 

Type of Information Collection Request: 

New. Need and Use of Information 

Collection: Health care costs are rising 

ceaselessly and there are currently no 

generally accepted way of controlling 

them. This study will access the 

experience of physicians regarding 

resource allocation in clinical practice, 

and how allocation decisions made at 

other levels shapes this experience. The 

primary objectives of the study are to 

determine if physicians make decisions 

to withhold interventions on the basis of 

cost, how often they report doing so, 

what types of care are withheld, and 

what criteria are used in making such 

decisions. The findings will provide 

valuable information concerning: (1) 

The practice of resource allocation in 

clinical practice, (2) the possible effects 

of perceived constraints on this practice; 

and (3) international comparisons on 

these two aspects. Frequency of 

Response: Once. Affected Public: 

Individuals or households; Businesses 

or other for-profit; Not-for-profit 

institutions. Type of Respondents: 

Physicians. The annual reporting 

burden is as follows: Estimated Number 

of Respondents: 250; Estimated Number 

of Responses per Respondent: 1; 

Average Burden Hours per Response: 

0.3674; and Estimated Total Annual 

Burden Hours Requested: 91.85. The 

annualized cost to respondents is 

estimated at: $5,218. There are no 

Capital Costs, Operating Costs and/or 

Maintenance Costs to report. 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies should 

address one or more of the following 

points: (1) Evaluate whether the 

proposed collection of information is 

necessary for the proper performance of 

the function of the agency, including 

whether the information will have 

practical utility; (2) Evaluate the 

accuracy of the agency’s estimate of the 

burden of the proposed collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Enhance the quality, utility, and 

clarity of the information to be 

collected; and (4) Minimize the burden 

of the collection of information on those 

who are to respond, including the use 

of appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, New Executive 

Office Building, Room 10235, 

Washington, DC 20503, Attention: Desk 

Officer for NIH. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact: Dr. 

Marion Danis, Department of Bioethics, 

DCB, CC, NIH, Building 10, Room 1C 

118, 9000 Rockville Pike, Bethesda, MD 

20892–1156, or call non-toll-free 

number 301–435–8727 or e-mail your 

request, including your address to: 

mdanis@cc.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30-days of the date of 

this publication. 

Dated: July 24, 2007. 

David K. Henderson, 

Deputy Director, Warren G. Magnuson 

Clinical Center, National Institutes of Health. 

Rebecca Chen, 

Senior Department Administrator, 

Department of Clinical Bioethics, Warren G. 

Magnuson Clinical Center, National Institutes 

of Health. 

[FR Doc. 07–3681 Filed 7–27–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Research 

Resources; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of a meeting of the 

National Advisory Research Resources 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals, and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Research Resources Council. 

Date: September 11, 2007. 

Open: 8 a.m. to 12:30 p.m. 

Agenda: NCRR Director’s Report and other 

business of the Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, Room 

10, Bethesda, MD 20892. 

Closed: 1:15 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, Floor 6C, Room 

10, Bethesda, MD 20892. 

Contact Person: Louise E. Ramm, PhD, 

Deputy Director, National Center for 

Research Resources, National Institutes of 

Health, Building 31, Room 3B11, Bethesda, 

MD 20892, 301–496–6023, 

louiser@ncrr.nih.gov. 

Any member of the public interested in 

presenting oral comments to the committee 

may notify the Contact Person listed on this 

notice at least 10 days in advance of the 

meeting. Interested individuals and 

representatives of organizations may submit 

a letter of intent, a brief description of the 

organization represented, and a short 

description of the oral presentation. Only one 

representative of an organization may be 

allowed to present oral comments and if 

accepted by the committee, presentations 

may be limited to five minutes. Both printed 

and electronic copies are requested for the 

record. In addition, any interested person 

may file written comments with the 

committee by forwarding their statement to 

the Contact Person listed on this notice. The 

statement should include the name, address, 

telephone number and when applicable, the 

business or professional affiliation of the 

interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institutes’s/Center’s home page: http:// 

www.ncrr.nih.gov/newspub/minutes.htm, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research; 93.371, Biomedical 

Technology; 93.389, Research Infrastructure, 

mstockstill on PROD1PC66 with NOTICES